Trajan Group Holdings Limited (TRJNF)

Market Cap	45.17M -41.7%
Revenue (ttm)	113.07M +6.2%
Net Income	-919.82K
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	11.71
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,000
Average Volume	7,200
Open	0.4000
Previous Close	0.5000
Day's Range	0.4000 - 0.4000
52-Week Range	0.4000 - 0.5000
Beta	0.42
RSI	n/a
Earnings Date	May 27, 2026

About Trajan Group Holdings

Trajan Group Holdings Limited develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India. The company offers analytical products, including syringes, GC columns and septa, inlet liners, rings, and tubing products; and sampling products, comprising septa, caps, liners, well plates and sealing mats, crimping tools, and micro sampling tools, as well as automation systems and consumables. It also provides pathology produ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2011
• Employees: 630
• Stock Exchange: OTCMKTS
• Ticker Symbol: TRJNF

Financial Performance

In fiscal year 2025, Trajan Group Holdings's revenue was 166.46 million, an increase of 7.38% compared to the previous year's 155.02 million. Losses were -4.46 million, -82.39% less than in 2024.

Financial numbers in AUD